Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

IGF-1

Insulin-like Growth Factor 1, Somatomedin C

Quick Stats
Studies 92
Trials 100
Withdrawn NA INTERVENTIONAL NCT01582685

Exercise in Breast Cancer Survivors

View on ClinicalTrials.gov Updated Dec 15, 2025

Brief Summary

The investigators hypothesize that exercise in postmenopausal breast cancer survivors will result in an increase in the plasma concentrations of angiostatic factors and a decrease in the plasma concentrations of angiogenic factors. Exercise is expected to result in a circulating angiostatic phenotype that inhibits adipose tissue mass, growth of breast cancer tumor, growth of microscopic residual disease after breast cancer resection, decreases rates of local-regional recurrence, decreases rates of distant recurrence, and increases survival.

Interventions

Name: Exercise
Type: BEHAVIORAL
Description: The participant will exercise for 16 weeks under supervision. The exercise regimen is increased slowly over 16 weeks.

Primary Outcomes

Measure: Number of participants that complete the study as a measure of feasibility of an exercise intervention in obese breast cancer survivors.
TimeFrame: 12 months
Description: Number of participants that enroll in the study and actually complete the study

Trial Information

NCT ID

NCT01582685

Status

Withdrawn

Study Type

INTERVENTIONAL

Phases

NA

Sponsor

University of Mississippi Medical Center

Last Updated

December 15, 2025